[1] |
Andelic N. The epidemiology of traumatic brain injury[J]. Lancet Neurol, 2013, 12(1): 28-29.
|
[2] |
Jennett B. Epidemiology of head injury[J]. Arch Dis Child, 1998, 78(5): 403-406.
|
[3] |
Stein SC,Georgoff P,Meghan S, et al. 150 years of treating severe traumatic brain injury: A systematic review of progress in mortality[J]. J Neurotrauma, 2010, 27(7): 1343-1353.
|
[4] |
Rosenfeld JV,Maas AI,Bragge P, et al. Early management of severe traumatic brain injury[J]. Lancet, 2012, 380: 1088-1098.
|
[5] |
Verchère J,Blanot S,Vergnaud E, et al. Mortality in severe traumatic brain injury[J]. Lancet Neurol, 2013, 12: 426-427.
|
[6] |
Maas AI,Stocchetti N,Bullock R. Moderate and severe traumatic brain injury in adults[J]. Lancet Neurol, 2008, 7(8): 728-741.
|
[7] |
Jacobs B,Beems T,van der Vliet TM, et al. Computed tomography and outcome in moderate and severe traumatic brain injury: Hematoma volume and midline shift revisited[J]. J Neurotrauma, 2011, 28(2): 203-215.
|
[8] |
Farahvar A,Gerber LM,Chiu YL, et al. Increased mortality in patients with severe traumatic brain injury treated without intracranial pressure monitoring[J]. J Neurosurg, 2012, 117: 729-734.
|
[9] |
Chesnut RM,Temkin N,Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury[J]. N Engl J Med, 2012, 367: 2471-2481.
|
[10] |
Carney N,Lujan S,Dikmen S, et al. Intracranial pressure monitoring in severe traumatic brain injury in latin america: Process and methods for a multi-center randomized controlled trial[J]. J Neurotrauma, 2012, 29(11): 2022-2029.
|
[11] |
Meyfroidt G. Intracranial pressure monitoring in severe traumatic brain injury: The time for a randomized controlled trial is now[J]. Crit Care Med, 2012, 40(6): 1993-1994.
|
[12] |
Melhem S,Shutter L,Kaynar A. A trial of intracranial pressure monitoring in traumatic brain injury[J]. Crit Care, 2014, 18(1): 302.
|
[13] |
Murillo-Cabezas F,Godoy DA. Intracranial pressure monitoring in severe traumatic brain injury: A different perspective of the besttrip trial[J]. Med Intensiva, 2014, 38(4): 237-239.
|
[14] |
Sarrafzadeh AS,Smoll NR,Unterberg AW. Lessons from the intracranial pressure-monitoring trial in patients with traumatic brain injury[J]. World Neurosurg, 2014, 82(1-2): e393-395.
|
[15] |
Hawthorne C,Piper I. Monitoring of intracranial pressure in patients with traumatic brain injury[J]. Front Neurol, 2014, 5: 121.
|
[16] |
Nangunoori R,Maloney-Wilensky E,Stiefel M, et al. Brain tissue oxygen-based therapy and outcome after severe traumatic brain injury: A systematic literature review[J]. Neurocrit Care, 2012, 17(1): 131-138.
|
[17] |
Rosenthal G,Furmanov A,Itshayek E, et al. Assessment of a noninvasive cerebral oxygenation monitor in patients with severe traumatic brain injury[J]. J Neurosurg, 2014, 120(4): 901-907.
|
[18] |
Haddad SH,Arabi YM. Critical care management of severe traumatic brain injury in adults[J]. Scand J Trauma Resusc Emerg Med, 2012, 20: 12.
|
[19] |
Timofeev I,Carpenter KL,Nortje J, et al. Cerebral extracellular chemistry and outcome following traumatic brain injury: A microdialysis study of 223 patients[J]. Brain, 2011, 134(Pt2): 484-494.
|
[20] |
Kennedy RT. Emerging trends in in vivo neurochemical monitoring by microdialysis[J]. Curr Opin Chem Biol, 2013, 17(5): 860-867.
|
[21] |
Nordström CH,Reinstrup P,Xu W, et al. Assessment of the lower limit for cerebral perfusion pressure in severe head injuries by bedside monitoring of regional enegy metabolism[J]. Anesthesiology, 2003, 98(4): 809-814.
|
[22] |
Hlatky R,Valadka AB,Goodman JC, et al. Patterns of energy substrates during ischemia measured in the brain by microdialysis[J]. J Neurotrauma, 2004, 21(7): 894-906.
|
[23] |
Dienel GA. Lactate shuttling and lactate use as fuel after traumatic brain injury: Metabolic considerations[J]. J Cereb Blood Flow Metab, 2014, 34(11): 1736-1748.
|
[24] |
Baines CP,Kaiser RA,Purcell NH, et al. Loss of cyclophilin d reveals a critical role for mitochondrial permeability transition in cell death[J]. Nature, 2005, 434(7033): 658-662.
|
[25] |
Marechal X,Montaigne D,Marciniak C, et al. Doxorubicin-induced cardiac dysfunction is attenuated by ciclosporin treatment in mice through improvements in mitochondrial bioenergetics[J]. Clin Sci (Lond), 2011, 121(9): 405-413.
|